Analysis of expression of the PD-1/PD-L1 immune checkpoint system and its prognostic impact in gastroenteropancreatic neuroendocrine tumors

The immune checkpoint based therapy targeting the programmed death-1 (PD-1) receptor and its PD-L1 ligand has recently been approved for the therapy of different malignant conditions, but not yet for gastroenteropancreatic neuroendocrine tumors (GEP-NETs). In this context, we evaluated the expressio...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Sci Rep
Main Authors: Sampedro-Núñez, Miguel, Serrano-Somavilla, Ana, Adrados, Magdalena, Cameselle-Teijeiro, José M., Blanco-Carrera, Concepción, Cabezas-Agricola, José Manuel, Martínez-Hernández, Rebeca, Martín-Pérez, Elena, Muñoz de Nova, José Luis, Díaz, José Ángel, García-Centeno, Rogelio, Caneiro-Gómez, Javier, Abdulkader, Ihab, González-Amaro, Roberto, Marazuela, Mónica
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Publishing Group UK 2018
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6292913/
https://ncbi.nlm.nih.gov/pubmed/30546030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-36129-1
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים